Merck
  • Home
  • Search Results
  • An efficient one-pot synthesis of benzothiazolo-4β-anilino-podophyllotoxin congeners: DNA topoisomerase-II inhibition and anticancer activity.

An efficient one-pot synthesis of benzothiazolo-4β-anilino-podophyllotoxin congeners: DNA topoisomerase-II inhibition and anticancer activity.

Bioorganic & medicinal chemistry letters (2010-12-15)
Ahmed Kamal, B Ashwini Kumar, Paidakula Suresh, Nagula Shankaraiah, M Shiva Kumar
ABSTRACT

An efficient one-pot iodination methodology for the synthesis of benzothiazolo-4β-anilino-podophyllotoxin (5a-h) and benzothiazolo-4β-anilino-4-O-demethylepipodophyllotoxin (6a-h) congeners has been successfully developed by using zirconium tetrachloride/sodium iodide. Interestingly, this protocol demonstrates enhancement of stereoselectivity apart from the improvement in the yields in comparison to previous methods reported for such related podophyllotoxin derivatives. These compounds have been designed and synthesized using association strategy by coupling of 4β-podophyllotoxin and 4β-demethylepipodophyllotoxin with a variety of substituted aminoaryl benzothiazoles. Some of the representative compounds have been evaluated for their cytotoxicity against selected human cancer cell lines and DNA topoisomerase-II inhibition activity.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Zirconium(IV) chloride, anhydrous, powder, 99.99% trace metals basis
Sigma-Aldrich
Podophyllotoxin
Sigma-Aldrich
Zirconium(IV) chloride, ≥99.9% trace metals basis
Sigma-Aldrich
Zirconium(IV) chloride, ≥99.5% trace metals basis
Sigma-Aldrich
Doxorubicin hydrochloride, suitable for fluorescence, 98.0-102.0% (HPLC)
Sigma-Aldrich
Doxorubicin hydrochloride, 98.0-102.0% (HPLC)